Can You “Do it Better”? Applying New Strategies into Obesity Care
Provided by Clinical Care Options, LLC in partnership with RealCME
This activity is supported by an educational grant from Lilly.
Upon completion of this activity, learners should be able to:
- Assess patients according to the guideline criteria for diagnosis and pharmacologic management of obesity
- Develop strategies to overcome biases and barriers associated with the chronic management of obesity
- Integrate shared decision-making techniques into patient interactions on obesity management
- Incorporate guideline recommendations, the latest clinical evidence, and patient-specific factors to select antiobesity medications for long-term management among appropriate patients
- Apply strategies to improve the likelihood of long-term weight loss based on an assessment of treatment response, patient preferences, and adherence
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity.
Robert Kushner, MD, MS: consultant/advisor/speaker: Epitomee, Lilly, Novo Nordisk, Pfizer, WW.
Christopher D. Still, DO, FACN, FACP: consultant/advisor/speaker: Novo Nordisk; researcher: Ethicon Endo-Surgery.
The planners and content peer reviewers from Clinical Care Options, LLC and RealCME do not have any relevant financial relationships to disclose, except Amy Butts, PA-C, as noted below.
Amy Butts, PA-C: consultant: Bayer, Novo Nordisk, Provention Bio, Xeris.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Learners have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by healthcare professionals without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
The primary target audience for this education is primary care physicians. The secondary target audience is primary care nurse practitioners and physician associates/physician assistants.
The goal of this program is to improve primary care provider knowledge and competence (application of knowledge) and demonstrate improvement in clinical performance to optimize treatment for patients with obesity.
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.
Physician Assistant/Physician Associate Continuing Medical Education
Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until 5/18/24. PAs should only claim commensurate with the extent of their participation.
This program has been made available online.
Instructions for Credit
Participation in this self-study activity should be completed in approximately 1.0 hour. To successfully complete this activity and receive credit, learners must follow these steps during the period from 5/18/23, through 5/18/24:
- Read the target audience, learning objectives, and faculty disclosures
- View and study the content in its entirety
- Submit answers to the post-test questions and evaluation questions online
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. You will be able to claim your credit and certificate immediately after completing the activity. There are no costs/fees for this activity.